Prednisone for acute virus-associated wheeze in children: Panacea or one more brick in the wall? - 05/03/15
Doi : 10.1016/j.jaci.2014.10.056
W. Gerald Teague, MD ⁎ 
Child Health Research Institute and the Division of Respiratory Medicine, Allergy, and Immunology, University of Virginia School of Medicine, Charlottesville, Va
∗Corresponding author: W. Gerald Teague, MD, University of Virginia School of Medicine, Division of Respiratory Medicine, Allergy, and Immunology, Charlottesville, VA 22908.
Key words : Prednisone, prednisolone, wheeze, children, human rhinovirus, viral load
Le texte complet de cet article est disponible en PDF.
| Disclosure of potential conflict of interest: W. Gerald Teague has received research support from the American Lung Association Asthma Clinical Research Center and the National Institutes of Health/National Heart, Lung, and Blood Institute (5U10HL109250-05); has received consultancy fees from Boehringer and Genentech; and has received lecture fees from Genentech and Merck. |
© 2014
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 135 - N° 3
P. 699-700 - mars 2015 Retour au numéro
Article précédent
- Fraction of exhaled nitric oxide measurements and asthma control: Are the numbers starting to add up?
- Louise Fleming, Andrew Bush
- Efficacy of nasal mometasone for the treatment of chronic sinonasal disease in patients with inadequately controlled asthma
- American Lung Association–Asthma Clinical Research Centers' Writing Committee:, Anne E. Dixon, Mario Castro, Rubin I. Cohen, Lynn B. Gerald, Janet T. Holbrook, Charles G. Irvin, Shyam Mohapatra, Stephen P. Peters, Sobharani Rayapudi, Elizabeth A. Sugar, Robert A. Wise
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?